Lanxess: Declines in Sales and Earnings in 2025 – 550 Job Cuts Planned

Lanxess closed fiscal year 2025 with declining key figures. Sales fell by 10.9 percent to €5.673 billion, while EBITDA before exceptional items decreased by 16.9 percent to €510 million. The EBITDA margin dropped from 9.6 percent to 9.0 percent. According to the specialty chemicals company, the reasons include persistently weak demand in many customer industries, lower selling prices as a result of reduced raw material costs, price pressure from Asia, negative currency effects, and the loss of earnings contributions from the Urethane Systems business, which was sold effective April 1, 2025.

Advert

For 2026, Lanxess expects a business recovery no earlier than the second half of the year and forecasts EBITDA before exceptional items in a range of €450 million to €550 million. At the same time, the company has launched further cost-cutting measures. By the end of 2028, an additional approximately €100 million per year is to be saved. Among the measures planned is the reduction of 550 jobs, mainly in administrative functions. Net financial debt declined by 15.0 percent at the end of 2025 to €2.023 billion. Among the segments, Consumer Protection remained stable in terms of earnings, while Specialty Additives and especially Advanced Intermediates recorded significant declines in earnings.

More information: lanxess.com

Lanxess AG, Cologne, Germany